drugset / Trial / NCT02169219
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this pilot study is to test whether an 8-week course of glucocorticoids, combined with rituximab, is effective in treating ANCA-associated vasculitis.
Timeline
- Start
- 2014-06
- Primary completion
- 2016-08-17
- Completion
- 2017-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylprednisolone | Other / unclassified | 1 g | Intravenous |
| Subject | Prednisone | Other / unclassified | 1 mg/kg | Oral |
| Subject | Prednisone | Other / unclassified | 60 mg | Oral |
| Subject | Rituximab | Monoclonal antibody | 375 mg/m2 | — |